Home  >  Products  >  CLK4 (CDC-like kinase 4) Blocking Peptide (the N terminal of CLK4)(100ug)
CLK4 (CDC-like kinase 4) Blocking Peptide (the N terminal of CLK4)(100ug)

CLK4 (CDC-like kinase 4) Blocking Peptide (the N terminal of CLK4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CLK4 Antibody(ARP30645_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP30645
Size: 100ug
Weight: 57kDa
Gene: 57396
Format: Lyophilized powder
Target: The protein encoded by this gene belongs to the CDC2-like protein kinase (CLK) family. This protein kinase can interact with and phosphorylate the serine- and arginine-rich (SR) proteins, which are known to play an important role in the formation of spliceosomes, and thus may be involved in the regulation of alternative splicing. Studies in the Israeli sand rat Psammomys obesus suggested that the ubiquitin-like 5 (UBL5/BEACON), a highly conserved ubiquitin-like protein, may interact with and regulate the activity of this kinase. Multiple alternatively spliced transcript variants have been observed, but the full-length natures of which have not yet been determined.
Alternative names: DKFZp686A20267
See Full Product Listings >